Ventas, Inc. (VTR) Earnings Call Transcripts

46 earnings calls from February 2020 to July 30, 2026

NYSE US Real Estate Health Care REITs

Ventas, Inc.'s Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, Ventas, Inc. (VTR) reported strong financial performance, with normalized FFO per share of $0.97, reflecting a 9% year-over-year increase. Total company same-property NOI grew by 10%, driven primarily by an impressive 18% growth in the U.S. senior housing operating portfolio (SHOP). Management raised full-year normalized FFO guidance to a range of $3.85 to $3.90 per share, indicating continued confidence in the company's growth trajectory amidst robust demographic demand for senior housing.

Reported metrics

MetricValueContext
Normalized FFO per Share $0.97 (beat) vs $0.89 est, +9% YoY
Total Same-Property NOI Growth 10% (beat) vs 8% est, +10% YoY
U.S. SHOP NOI Growth 18% (beat) vs 15% est, +18% YoY
Occupancy Growth 360 bps (positive) year-over-year increase
Investment Guidance $4.5 billion (positive) raised from $3 billion
NOI Margin 31% (positive) up 210 bps YoY

Guidance from management

Management raised its full-year normalized FFO guidance to a range of $3.85 to $3.90 per share, reflecting an 8% to 10% growth rate, primarily due to increased investment activity and strong operational performance.

What management said

Good morning, Julien and Debbie here. Thanks for the question. Look, we've always taken the view that we'll strongly consider any transaction that we believe creates long-term value for shareholders, and we've proven that in the past with our SNF disposition and spin-off, we continue to evaluate our portfolio. Our strategy is very focused on expanding our SHOP footprint, and that's exactly what we're doing. And that'...
— Debra Cafaro, Q2 FY2026 earnings call
Sure. So we -- when I said in my remarks were we started the year with a 270 guide. We've raised it to 300 basis points of growth year-over-year. We started the year really strong. We had 310 in the first, we had 300 in the second. So that means we need around 300 for the rest of the year. We have good visibility into the key selling season. It's on track. There's good sales activity on the ground already in the quar...
— Robert Probst, Q2 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the sustainability of occupancy growth and the potential impact of rising interest rates on future performance. Questions were raised about whether the current growth rates could be maintained in the face of economic headwinds.

Main topics on the call

Read the full Ventas, Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Ventas, Inc.

Ventas, Inc. (VTR) is a publicly listed company in the Health Care REITs industry, within the Real Estate sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 46 calls on record spanning February 20, 2020 to July 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 46 Ventas, Inc. earnings call transcripts on record, spanning February 20, 2020 to July 30, 2026. Based on this history, Ventas, Inc. reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
VTR
Exchange
NYSE
Country
US
Sector
Real Estate
Industry
Health Care REITs
Calls on record
46
First call
February 20, 2020
Most recent
July 30, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 30, 2026 Read transcript
Q1 FY2026 Apr 28, 2026 Read transcript
Company Conference Presentations Mar 4, 2026 Read transcript
Company Conference Presentations Mar 3, 2026 Read transcript
Q4 FY2025 Feb 6, 2026 Read transcript
Q3 FY2025 Oct 30, 2025 Read transcript
Company Conference Presentations Sep 10, 2025 Read transcript
Q2 FY2025 Jul 31, 2025 Read transcript
Q1 FY2025 May 1, 2025 Read transcript
Company Conference Presentations Mar 4, 2025 Read transcript
Q4 FY2024 Feb 13, 2025 Read transcript
Q3 FY2024 Oct 31, 2024 Read transcript
Company Conference Presentations Sep 10, 2024 Read transcript
Q2 FY2024 Aug 2, 2024 Read transcript
Company Conference Presentations Jun 4, 2024 Read transcript
Q1 FY2024 May 2, 2024 Read transcript
Company Conference Presentations Mar 5, 2024 Read transcript
Q4 FY2023 Feb 15, 2024 Read transcript
Q3 FY2023 Nov 3, 2023 Read transcript
Company Conference Presentations Sep 12, 2023 Read transcript
Q2 FY2023 Aug 4, 2023 Read transcript
Company Conference Presentations Jun 6, 2023 Read transcript
Q1 FY2023 May 9, 2023 Read transcript
Company Conference Presentations Mar 7, 2023 Read transcript
Q4 FY2022 Feb 10, 2023 Read transcript
Q3 FY2022 Nov 4, 2022 Read transcript
Company Conference Presentations Sep 13, 2022 Read transcript
Q2 FY2022 Aug 5, 2022 Read transcript
Company Conference Presentations Jun 8, 2022 Read transcript
Q1 FY2022 May 6, 2022 Read transcript
Company Conference Presentations Mar 7, 2022 Read transcript
Q4 FY2021 Feb 18, 2022 Read transcript
Q3 FY2021 Nov 5, 2021 Read transcript
Q2 FY2021 Aug 6, 2021 Read transcript
Company Conference Presentations Jun 9, 2021 Read transcript
Shareholder/Analyst Calls May 25, 2021 Read transcript
Q1 FY2021 May 7, 2021 Read transcript
Company Conference Presentations Mar 9, 2021 Read transcript
Q4 FY2020 Feb 18, 2021 Read transcript
Company Conference Presentations Nov 17, 2020 Read transcript
Q3 FY2020 Nov 6, 2020 Read transcript
Q2 FY2020 Aug 7, 2020 Read transcript
Company Conference Presentations Jun 2, 2020 Read transcript
Shareholder/Analyst Calls May 18, 2020 Read transcript
Q1 FY2020 May 8, 2020 Read transcript
Q4 FY2019 Feb 20, 2020 Read transcript